Evoke Pharma Inc. (NASDAQ: EVOK)
$4.5600
+0.0600 ( +1.33% ) 11.2K
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Market Data
Open
$4.5600
Previous close
$4.5000
Volume
11.2K
Market cap
$6.61M
Day range
$4.4050 - $4.6550
52 week range
$3.5400 - $17.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Aug 13, 2024 |
10-q | Quarterly Reports | 42 | Aug 13, 2024 |
4 | Insider transactions | 1 | Aug 08, 2024 |
4 | Insider transactions | 1 | Aug 08, 2024 |
4 | Insider transactions | 1 | Aug 08, 2024 |
8-k | 8K-related | 12 | Aug 01, 2024 |
8-k | 8K-related | 12 | Jun 20, 2024 |
8-k | 8K-related | 11 | Jun 07, 2024 |
3 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 13 | May 28, 2024 |